[Progress in the area of drug development].
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D000700:Analgesics; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D002490:Central Nervous System / Q000187:drug effects; D004232:Diuretics; D005100:Expectorants; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D050356:Lipid Metabolism; D009125:Muscle Relaxants, Central; D009294:Narcotics; D010276:Parasympatholytics; D010525:Peripheral Nerves / Q000187:drug effects; D004364:Pharmaceutical Preparations; D012216:Rheumatic Diseases / Q000188:drug therapy; D012702:Serotonin Antagonists; D014665:Vasodilator Agents
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D000700:Analgesics; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004232:Diuretics; D005100:Expectorants; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D009294:Narcotics; D010276:Parasympatholytics; D004364:Pharmaceutical Preparations; D012702:Serotonin Antagonists; D014665:Vasodilator Agents
Fortschritte auf dem Gebiet der Arzneimittelentwicklung.